Ophthalmology 360
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Photo Contest
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
2nd Annual Photo Contest - Enter Here!
Ophthalmology 360
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Photo Contest
    • Industry Council
    • Advisory Board
Home > Neurotrophic Keratitis > New report highlights early, hidden forms of neurotrophic keratopathy in children
  • Neurotrophic Keratitis

New report highlights early, hidden forms of neurotrophic keratopathy in children

Ophthalmology 360

Key Takeaways

  1. Childhood neurotrophic keratopathy is often congenital or inherited and may present before visible corneal damage.
  2. The report proposes updating NK staging to include eyes with absent corneal sensation but a normal exam.

A new report describes key clinical features of neurotrophic keratopathy (NK) in children, noting that the condition is frequently congenital or inherited and may present before any visible corneal abnormalities are detected. The authors highlight that some children demonstrate absent corneal sensation despite a normal ocular examination, a presentation that is not currently captured by existing staging systems.

According to the report, pediatric NK has added visual significance because stromal opacification may place children at risk for amblyopia. In contrast to adult-onset NK, which is typically acquired, childhood disease is more commonly linked to genetic pain insensitivity syndromes, cranial dysinnervation disorders, or broader developmental anomalies.

The authors also note that visual function can remain well preserved in many affected children when supportive management or targeted medical and surgical interventions directed at sensory nerve function are used.

Based on these findings, the report proposes a modification to the current NK classification, adding a category for eyes with no detectable corneal sensation but otherwise normal clinical findings—a phenotype the authors state is commonly encountered in early-stage pediatric NK.

Reference

Jiang J, Ashton CBJ, Larkin DFP. Neurotrophic keratopathy in childhood: advances in understanding of pathogenesis and management. Eye (Lond). 2026;doi: 10.1038/s41433-026-04278-7. Epub ahead of print. PMID: 41644711.

Share

Related Content

  • Pediatrics

FDA authorization of Stellest leads to an increase in searches for pediatric myopia-control spectacles

  • Neurotrophic Keratitis

Cenegermin improves corneal healing in moderate to severe neurotrophic keratitis

  • Glaucoma

Glaucoma drainage devices provide meaningful IOP control in pediatric glaucoma

  • Retina Care 360

Cost analysis shows greater losses for pediatric versus adult retinal detachment repairs

  • Glaucoma

PreserFlo MicroShunt shows short-term benefit in refractory childhood glaucoma

  • Neurotrophic Keratitis

Shelf-stable amniotic membrane improved outcomes in early-stage neurotrophic keratopathy

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Ophthalmology 360

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon